Emtaf-B Tablet

Produktübersicht

About Emtaf-B Tablet

Emtaf-B Tablet is a medication containing the active ingredient Tenofovir Alafenamide, classified as Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor. 1 INDICATIONS AND USAGE BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg: who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Tenofovir Alafenamide, the active ingredient in Emtaf-B Tablet, belongs to the Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor class. 1 INDICATIONS AND USAGE BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg: who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Emtaf-B Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Emtaf-B Tablet for extended periods without medical advice.